Quick Answer
ANAPTYSBIO, INC reported Total Revenue of $234.60 million for the year ending 2025.
- ANAPTYSBIO, INC showed an increase of +157.0% in Total Revenue from 2024 to 2025.
- This data is from ANAPTYSBIO, INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $0.00 | Q3 2018: $5.00 million | Q1 2019: $0.00 | Q2 2019: $5.00 million | Q3 2019: $0.00 | Q1 2020: $15.00 million | Q2 2020: $0.00 | Q3 2020: $0.00 | Q1 2021: $11.25 million | Q2 2021: $30.03 million | Q3 2021: $20.89 million | Q1 2022: $970.0 thousand | Q2 2022: $1.22 million | Q3 2022: $1.29 million | Q1 2023: $1.37 million | Q2 2023: $3.46 million | Q3 2023: $3.32 million | Q1 2024: $7.18 million | Q2 2024: $10.97 million | Q3 2024: $30.02 million | Q1 2025: $27.77 million | Q2 2025: $22.26 million | Q3 2025: $76.32 million.
- Over the full 9 years of available data (2017 to 2025), ANAPTYSBIO, INC's Total Revenue has grown by 2,246.0%.
- Historical annual values: Fiscal year 2025: $234.60 million | Fiscal year 2024: $91.28 million | Fiscal year 2023: $17.16 million | Fiscal year 2022: $10.29 million | Fiscal year 2021: $63.18 million | Fiscal year 2020: $75.00 million | Fiscal year 2019: $8.00 million | Fiscal year 2018: $5.00 million | Fiscal year 2017: $10.00 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: